You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intermediate or high risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)

Recruiting
  • Pulmonary Embolism
  • ultrasound-assisted, catheter-directed thrombolysis
  • Milano, Italia, Italy
    ASST GOM Niguarda
Nov 21, 2023

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary

Recruiting
  • Pulmonary Embolism
  • Tissue Plasminogen Activator, Alteplase
  • Low-molecular weight heparin
  • İzmir, Bornova/İzmir, Turkey
    Ege University
Aug 22, 2022

Pulmonary Embolism Trial in Bispebjerg, Copenhagen, Herlev (Alteplase 20 Mg Powder for Solution for Injection Vial, Ultrasound

Recruiting
  • Pulmonary Embolism
  • Alteplase 20 Mg Powder for Solution for Injection Vial
  • Ultrasound assisted Thrombolysis
  • Bispebjerg, Denmark
  • +2 more
Oct 25, 2022

Pulmonary Embolism Trial in Prague (Thrombolytic, Standard anticoagulation)

Not yet recruiting
  • Pulmonary Embolism
  • Prague, Czechia
    University Hospital Kralovske Vinohrady
Aug 5, 2022

Pulmonary Embolism Acute Trial (Anticoagulation, mechanical aspiration thrombectomy)

Not yet recruiting
  • Pulmonary Embolism Acute
  • (no location specified)
Jan 12, 2023

Pulmonary Embolism Trial in Leipzig (combined catheter-thrombectomy and local fibrinolysis, conventional treatment)

Recruiting
  • Pulmonary Embolism
  • combined catheter-thrombectomy and local fibrinolysis
  • conventional treatment
  • Leipzig, Saxony, Germany
    Heart Center Leipzig at University of Leipzig
Jul 9, 2022

Intermediate to High-risk Asymptomatic Sportsmen With Exercise

Completed
  • Electrocardiography
  • Screening stress test on a bicycle ergometer (usual practise)
  • Saint-Étienne, France
    Centre Hospitalier de Saint-Etienne
Sep 6, 2023

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Oropharynx Squamous Cell Carcinoma
  • Nivolumab Injection
  • Radiotherapy (RT)
  • Atlanta, Georgia
  • +2 more
Mar 24, 2022

Screening CEDM in Intermediate and High-Risk Patient Populations

Completed
  • Breast Cancer
  • Contrast Enhanced Digital Mammography
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 18, 2023

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • (no location specified)
Oct 27, 2022

Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • Radiotherapy - Low risk group
  • +3 more
  • (no location specified)
Sep 18, 2023

Pulmonary Embolism, Pulmonary Thromboembolisms, Embolism, Pulmonary Trial in Tehran (Conventional catheter-directed thrombolysis

Terminated
  • Pulmonary Embolism
  • +3 more
  • Conventional catheter-directed thrombolysis (CDT) with recombinant tissue plasminogen activator (rtPA)
  • Enoxaparin
  • Tehran, Iran, Islamic Republic of
    Rajaie Cardiovascular Medical and Research Center
Dec 28, 2021

Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

Recruiting
  • Bladder Cancer
  • Pseudomonas aeruginosa
  • Jinan, Shandong, China
    Qilu hospital
Jul 26, 2023

Pancreatic Fistula Trial in Cleveland (Piperacillin/Tazobactam, Amoxicillin/ Clavulanic acid)

Not yet recruiting
  • Pancreatic Fistula
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Feb 22, 2023

MDS Trial in Bronx (Pyrimethamine)

Withdrawn
  • Myelodysplastic Syndromes
  • Bronx, New York
    Montefiore Medical Center
Sep 15, 2021

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Prostate Cancer Trial in Rome (Decapeptyl)

Recruiting
  • Prostate Cancer
  • Rome, Lazio, Italy
  • +2 more
Sep 23, 2022

Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)

Recruiting
  • Myelofibrosis
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Intermediate and High-Risk Bladder Cancer Patients

    Recruiting
    • Urothelial Bladder Cancer
    • CxBladder Monitor
    • White River Junction, Vermont
    • +1 more
    Sep 12, 2022